- Details
- Description
-
Packaging Size1Bottle/Box
-
Strength100mg/10ml
-
CompositonRipertamab
-
TreatmentDiffuse large B lymphoma,DLBCL
-
FormInjection
-
Brand安平希
-
Quantity Unit100mg(10ml)*1Bottle/Box
-
ManufacturerSinocelltech Group Ltd.,China
Ripertamab (SCT400) is a recombinant, human-mouse chimeric anti-CD20 IgG1κ mAb.
- Ripertamab sold under the brand name 安平希® in china.
Ripertamab approval from China’s NMPA to treat patients with CD20-positive diffuse large B-cell lymphoma. The country’s first homegrown anti-CD20 therapy, ripertamab has been shown to have similar efficacy to global blockbuster rituximab but with a superior safety profile.